Expansion of structure, site and spectrum: TRACOE medical records positive results for 2018

»» Group revenues increased by 10% to approx. EUR 33 million

»» Systematic preparation for the Medical Device Regulation

»» Significant growth in employee numbers by 10.5%

Thus, with total revenues of around EUR 33 million, the XTR Group, parent company not only of TRACOE medical, but also its UK subsidiary KAPITEX Healthcare Ltd and the Dutch company MC Europe B. V., significantly increased its total revenue by 10%. Of this, TRACOE medical alone posted revenue of around EUR 24 million, an increase of 13% over the previous year.

With the foundation of a subsidiary in Austria, the commissioning of its own silicone production facility and the introduction of a significant product line, the focus last year for TRACOE medical was above all the optimisation of the corporate structure and expansion of the site facilities and product range. “Last year we succeeded in continuing our growth course. Important strategic steps, such as the introduction of a product line for neonates and children or the establishment of our first TRACOE subsidiary in Austria, have laid the foundation for this,” says Stephan Köhler, Managing Director of TRACOE medical.

Find more information here.

Bitte verwenden Sie einen anderen Browser

Internet Explorer ist ein veralteter Browser der von uns nicht mehr unterstützt wird. Bitte verwenden Sie einen aktuellen Browser, wie Microsoft Edge, Google Chrome oder Safari, für das beste Website-Erlebnis.